Related Experiment Video
Updated: May 4, 2026

10:28
Development of an In Vitro Assay to Quantitate Hematopoietic Stem and Progenitor Cells HSPCs in Developing Zebrafish Embryos
Published on: November 30, 2017
7.7K
Summary
Loss of phosphatase and tensin homolog (Pten) in zebrafish significantly boosts hematopoietic stem cell (HSC) proliferation. This Pten deficiency also halts the differentiation of blood progenitor cells, offering insights into early cancer development.
Area of Science:
- Hematology
- Cancer Biology
- Developmental Biology
Background:
- The phosphatase and tensin homolog (Pten) gene is a critical tumor suppressor.
- Dysregulation of Pten is implicated in various human cancers, including hematological malignancies.
- Understanding Pten's role in early hematopoiesis is crucial for deciphering leukemogenesis.
Purpose of the Study:
- To investigate the function of Pten in hematopoietic stem cell (HSC) regulation.
- To elucidate the impact of Pten loss on blood progenitor cell differentiation.
- To identify early genetic events contributing to malignant transformation in blood cells.
Main Methods:
- Utilized a zebrafish model with targeted phosphatase and tensin homolog (Pten) deficiency.
- Analyzed hematopoietic stem cell proliferation and behavior in vivo.
- Examined the differentiation status of lineage-committed blood progenitor cells.
Main Results:
- Pten deficiency markedly enhances the proliferation of hematopoietic stem cells (HSCs).
- Loss of Pten function leads to a differentiation arrest in lineage-committed blood progenitor cells.
- These findings highlight Pten's role in maintaining normal blood cell development and preventing aberrant growth.
Conclusions:
- Pten loss is a significant driver of early hematopoietic abnormalities.
- The study provides novel insights into genetic events predisposing blood cells to malignancy.
- Targeting Pten pathways may offer therapeutic strategies for hematological cancers.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Hematopoiesis
8.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.1K

